ADOLORE BIOTHERAPEUTICS, INC.

Profile

Company Names

ADOLORE BIOTHERAPEUTICS, INC.

Addresses

13685 WHISTLER MOUNTAIN ROAD, DELRAY BEACH, FL 33446

Phone Numbers

973-524-0935

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$1,330,000.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-09-10 
$25,000.00 
$1,000,000.00 
$975,000.00 
Debt 
2
2023-12-15 
$1,055,000.00 
INDEFINITE 
INDEFINITE 
Debt 
1
2022-01-06 
$250,000.00 
$2,500,000.00 
$2,250,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LOU 
 
ALTIERI 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
FLOWONIX MEDICAL INC   |  ADOLORE BIOTHERAPEUTICS, INC.
PAUL 
 
BARONE 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ONSPIRA THERAPEUTICS, INC.   |  ADOLORE BIOTHERAPEUTICS, INC.
PAUL 
HENRY 
BARONE 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ADOLORE BIOTHERAPEUTICS, INC.
ROY 
 
LEVITT 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ONSPIRA THERAPEUTICS, INC.   |  ADOLORE BIOTHERAPEUTICS, INC.
MARK 
 
ROGERS 
DIRECTOR
ENTERTAINMENTXPRESS, INC.   |  ALCHEMY STRUCTURED INVESTMENTS, INC.   |  SAFE FOODS CORP   |  RISTA HOLDINGS, INC.   |  IMPARTNER, INC.   |  WIBOTIC INC.   |  LUX ICE, LLC   |  ADOLORE BIOTHERAPEUTICS, INC.   |  HOME EQUITY INVESTMENT FUND 1, LLC   |  GIBSON ONCOLOGY, LLC
ROELOF 
 
RONGEN 
EXECUTIVE OFFICER, DIRECTOR
MATINAS BIOPHARMA, INC.   |  MATINAS BIOPHARMA HOLDINGS, INC.   |  GRI BIO, INC.   |  ADOLORE BIOTHERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-09-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-09-10 
2024-01-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-12-15 
2022-01-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-01-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#